(Q47865433)

6 February 2018

title

Regulatory T cells in Behçet's disease: is there a correlation with disease activity? Does regulatory T cell type matter? (English)

1 reference

6 February 2018

0 references

Cengiz Bal

5

0 references

author name string

Eren Gündüz

1

1 reference

6 February 2018

Hava Usküdar Teke

2

1 reference

6 February 2018

Nazife Sule Yaşar Bilge

3

1 reference

6 February 2018

Döndü Usküdar Cansu

4

1 reference

6 February 2018

Cengiz Korkmaz

6

1 reference

6 February 2018

Zafer Gülbaş

7

1 reference

6 February 2018

publication date

3 August 2013

1 reference

6 February 2018

Rheumatology International

published in

1 reference

6 February 2018

volume

33

1 reference

6 February 2018

issue

12

1 reference

6 February 2018

page(s)

3049-3054

1 reference

6 February 2018

https://scigraph.springernature.com/pub.10.1007/s00296-013-2835-8

exact match

0 references

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2835-8

A proposed classification of the immunological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2835-8

CD4+ FoxP3+ regulatory T cells confer infectious tolerance in a TGF-beta-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2835-8

Moving to tolerance: clinical application of T regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2835-8

Behçet's disease: evaluation of a new instrument to measure clinical activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2835-8

New insights into the pathogenesis of Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2835-8

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2835-8

Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2835-8

RORC and Foxp3 axis in cerebrospinal fluid of patients with neuro-Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2835-8

Critical role of IL-21 in modulating TH17 and regulatory T cells in Behçet disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2835-8

Characteristics of T cell lines established from skin lesions of Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2835-8

Regulatory T-cell therapy: is it ready for the clinic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2835-8

In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2835-8

Regulatory T cells in spontaneous autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2835-8

CD4+ CD25+ regulatory T cells ameliorate Behcet's disease-like symptoms in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2835-8

Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease

21 January 2018

1 reference

12 December 2020

Decreased percentages of regulatory T cells in peripheral blood of patients with Behcet's disease before ocular attack: a possible predictive marker of ocular attack

1 reference

12 December 2020

[The changes of Th lymphocyte subsets in patients with Behcet disease]

1 reference

12 December 2020

CD4+CD25+ regulatory T cells in patients with Behçet's disease.

1 reference

12 December 2020

Interleukin-2, interleukin-6 and T regulatory cells in peripheral blood of patients with Behçet’s disease and recurrent aphthous ulcerations

1 reference

12 December 2020

Paradoxical high regulatory T cell activity in Behçet's disease.

1 reference

12 December 2020

Induction of regulatory T cells by infliximab in Behcet's disease

1 reference

12 December 2020

10.1007/S00296-013-2835-8

Identifiers

DOI

1 reference

6 February 2018

PubMed ID

23912800

1 reference

6 February 2018